T2 Mapping Identifies Early Anthracycline-Induced Cardiotoxicity in Elderly Patients With Cancer.

Current measures of anthracycline-induced cardiotoxicity, defined by decreases in left ventricular ejection fraction (LVEF), may become apparent only at a late stage when the myocardium has been significantly damaged, exceeding its ability to compensate ([1][1]). Our group has recently shown in a